Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8459581 | Radiotherapy and Oncology | 2014 | 6 Pages |
Abstract
Based on published literature, one would have expected a higher LRR rate in the I risk group without adjuvant RT. We hypothesise that the I risk group LRR rates have been reduced to that of the L risk group by the addition of RT. Apart from LN status and tumour size, other prognostic factors should also be considered in selecting patients for PMRT. This pragmatic tool requires further validation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Mukesh B. Mukesh, Simon Duke, Deepak Parashar, Gordon Wishart, Charlotte E. Coles, Charles Wilson,